The administration released its FY20 budget today including a $4.7 billion cut for medical research at the National Institutes of Health (NIH) including a nearly $900 million cut for the National Cancer Institute (NCI).
The American Cancer Society Cancer Action Network hosted its fourth annual Cancer Research Breakfast this morning at the Inova Center for Personalized Health Conference Center. The event featured cancer researchers from five of Virginia’s leading research institutions, discussing the latest breakthroughs in the battle against cancer.
The Senate Appropriations Committee approved its FY 2019 Labor, Health and Human Services spending bill today. The bill includes a $2 billion funding increase for the National Institutes of Health (NIH) and a $190 million funding boost for the National Cancer Institute (NCI).
WASHINGTON, D.C. – Today the U.S. House of Representatives unanimously passed the Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act, sending the bill to the president’s desk for enactment.
Advocates from the American Cancer Society Cancer Action Network (ACS CAN) will be on Capitol Hill today asking Congress to support initiatives that would increase research and improve treatment for children with cancer.
As a child, she struggled with low platelet and red blood cell counts — an unusual combination of anemia in children. Doctors kept an eye on her health, and it would be three years before a genetic test of her bone marrow identified a duplicate chromosome that would ultimately lead to her Myelodysplastic Syndrome (MDS). If untreated, MDS becomes leukemia.
The U.S. Senate passed the Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act. The bipartisan bill would advance pediatric cancer research and increase transparency and expertise for pediatric cancer research at the National Institutes of Health (NIH).
The bipartisan bill would advance pediatric cancer research and increase transparency and expertise for pediatric cancer research at the National Institutes of Health (NIH). Additionally, the legislation expands research into the long-term side effects of childhood cancer and its treatments
The Senate has advanced the U.S. Food and Drug Administration’s (FDA) Reauthorization Act, which expands four separate user fee agreements on new drugs, generic drugs, medical devices, and biosimilars, and includes a provision to maximize the development of therapies for children with cancer.
The president’s proposed 2018 budget, would decrease the National Institutes of Health budget by 21 percent, decrease the National Cancer Institute budget by 25 percent, cut the Centers for Disease Control and Prevention’s chronic disease program by nearly 20 percent and reduce Medicaid funding by more than $600 billion.